SNPX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Synaptogenix (SNPX) Ownership - Who owns Synaptogenix?

Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

1185 Avenue of the Americas

Phone

+1 973 242-0005

Employees

Web

https://www.synaptogen.com

Details

Group

Domestic Stock Funds

Fundamentals

SNPX

Capitalization

3.23M

P/E Ratio

2.75

Risk (Beta)

1.45

Dividend Yield

N/A

Total Cash

22.1M

Total Cash/Share

15.88

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

12.8M

P/B Ratio

0.55

Cash Flow

N/A

Earnings

0.88

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

137

Current Ratio

65.36

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-6.76M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-33.10

Shares Held By Institutions

83.4K

Shares Outstanding - Current

1.39M

Total Liabilities

9.71M

Total Volume MTD

N/A

Value

N/A

Gain YTD

-32.997

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology